The breakdown of reports of patient safety incidents on the National Reporting and Learning System of England and Wales is shown in the following table.
Incident category—level 1 Incident category—level 2 October 2005 to September 2006 October 2006 to September 2007 Clinical assessment (including diagnosis, scans, tests, assessments) Diagnosis—delay/failure to 130 169 Diagnosis—wrong 45 37 Scans/X-rays/specimens—inadequate/incomplete 33 51 Scans/X-rays/specimens—mislabelled/unlabelled 60 84 Scans/X-rays/specimens—missing 38 34 Tests—failure/delay to undertake 53 69 Documentation (including records, identification) Scans/X-rays/specimens—mislabelled/unlabelled 20 13 Scans/X-rays/specimens—missing 6 3 Implementation of care and ongoing monitoring/review Delay/failure in recognising complication of treatment 13 9 Tests—failure/delay to undertake 20 10 Infection control incident Diagnosis—delay/failure to 1 2 Diagnosis—wrong 0 1 Treatment, procedure Delay/failure in recognising complication of treatment 14 20 Total 433 502
An impact assessment was published at the same time as the new Cancer Reform Strategy (CRS) on 3 December 2007. A copy of the CRS Impact Assessment is available at
www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsLegislation/DH_081004
and is also available in the Library.
A breakdown of estimated additional costs associated with the extension of the 31-day standard is detailed in the following table.
Financial year Estimate for annual costs (£ million) 2008-09 2.1 2009-10 4.3 2010-11 6.4 2011-12 6.4 2012-13 6.4 2013-14 6.4 2014-15 6.4 2015-16 6.4 2016-17 6.4 2017-18 6.4
Funding for the extension of the 31-day standard is not separately identified in allocations to the national health service. Primary care trusts are funded to meet the health care needs of their populations, which will include the provision of cancer services.